Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

Sorafenib (Sor) is a multi-kinase inhibitor. It is recommended for the treatment of advanced hepatocellular carcinoma (HCC). However, Sor has severe and marked side effects. On the other hand, taurine (Tau) has been shown to enhance the therapeutic effects of cancer chemotherapy and also to enhance...

Descripción completa

Detalles Bibliográficos
Autores principales: Afifi, Ahmed M, El-Husseiny, Ahmed M, Tabashy, Reda H, Khalil, Mohamed A, El-Houseini, Motawa E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982677/
https://www.ncbi.nlm.nih.gov/pubmed/31653148
http://dx.doi.org/10.31557/APJCP.2019.20.10.3007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982677/
https://www.ncbi.nlm.nih.gov/pubmed/31653148
http://dx.doi.org/10.31557/APJCP.2019.20.10.3007

Ejemplares similares